TCL Archive NCI To Fund About 4,100 Grants; Increase Planned In Average Costs; Paylines Stable November 20, 1998
TCL Archive FDA advisors vote against recommending Johnson & Johnson’s Zarnestra for treatment of AML in the elderly. May 6, 2005